Cash & equivalents increased 110.4%
Cash & equivalents changed +110.4% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +110.4% from the comparable as-filed period.
Debt changed +30.2% from the comparable as-filed period.
Net income changed +60.4% from the comparable as-filed period.
Operating income changed +94.7% from the comparable as-filed period.
Operating margin changed +726 basis points from the comparable as-filed period.
Gross margin changed -83 basis points from the comparable as-filed period.
Gross profit changed +8.6% from the comparable as-filed period.
Research & development changed -11.6% from the comparable as-filed period.
Revenue changed +9.8% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.